| Net Cash Provided by (Used in) Operating Activities |
$577,173 |
USD |
-139% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$288,149 |
USD |
82% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$20,000 |
USD |
0% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
100,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
28,315,549 |
shares |
6.8% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$309,024 |
USD |
-199% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$1,476,432 |
USD |
101% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$1,499,427 |
USD |
104% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$627,100 |
USD |
100% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
10,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
$19,170,409 |
USD |
14% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |